SEARCH

SEARCH BY CITATION

References

  • 1
    Faich GA. Adverse drug-reaction monitoring. N Engl J Med 1986;65:448453.
  • 2
    Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclo-oxygenase enzymes. Ann Allergy Asthma Immunol 2001;87:177180.
  • 3
    Szczeklik A, Nizankowska E, Sanak M, Swierczynska M. Aspirin-induced rhinitis and asthma. Curr Opin Allergy Clin Immunol 2001;1:2733.
  • 4
    Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. Eur Respir J 2000;16:432436.DOI: 10.1034/j.1399-3003.2000.016003432.x
  • 5
    Johansson SGO, O'B Hourihane J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813824.
  • 6
    Marquette CH, Saulnier F, Leroy O, et al. Long-term prognosis for near fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for near attack of asthma. Am Rev Respir Dis 1992;146:7681.
  • 7
    Stevenson DD, Simon RA. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. In: MiddletonEJr, ReedCE, EllisEF, AdkinsonNF Jr, YungingerJW, BusseWW, editors. Allergy: Principles and Practice, 5th edn. St Louis: Mosby 1998, 12251234.
  • 8
    Settipane GA, Chafee FH, Klein DE. Aspirin intolerance. II. A prospective study in an atopic and normal population. J Allergy Clin Immunol 1974;53:200204.
  • 9
    Stevenson DD. Diagnosis, prevention and treatment of adverse reactions to aspirin and nonsteroidal antiinflammatory drugs. J Allergy Clin Immunol 1984;74:617622.
  • 10
    Hedman J, Kaprio J, Poussa T, Nieminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999;28:717722.
  • 11
    Sampson A. Drug-induced asthma. NSAIDs, beta-blockers, and ACE inhibitors. In: HolgateST, BousheyHA, FabbriLH, editors. Difficult Asthma. London: Martin Dunitz Ltd 1999, 127145.
  • 12
    Nasser SMS, Lee TH. Leukotrienes in aspirin-sensitive asthma. In. SzczeklikA, GryglewskiRJ, VaneJR, editors. Eicosanoids, Aspirin, and Asthma. New York. Basel, Hong Kong: Marcel Dekker, Inc. 1998, 317335.
  • 13
    Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Clinical patterns of hypersensitivity to nonsteroidal antiinflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977;60:276284.
  • 14
    Dahlén B, Zetterström O. Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmatics. Eur Respir J 1990;3:527534.
  • 15
    Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J 2000;15:863869.
  • 16
    Szczeklik ANizankowska E. Pharmacological agents in bronchial provocation tests. In: AllegraL, BragaPC, Dal NegroReditors. Methods in Asthmology. Berlin: Springer Verlag 1993, 253264.
  • 17
    Bianco S, Robuschi M, Patrigni G. Aspirin induced tolerance in aspirin-asthma detected by a new challenge test. J Med Sci 1977;5:129130.
  • 18
    Schmitz-Schumann M, Schaub E, Virchow C. Inhalative Provocation mit lysin-azetylsalizylsaure bei analgetica–asthma syndrome. Prax Pneumol 1982;36:1721.
  • 19
    Sakakibara H, Tsuda M, Suzuki M, et al. A new method of diagnosis of aspirin-induced asthma by inhalation test with water solution aspirin. J Jap Thor Dis 1988;26:275283.
  • 20
    Philips GD, Foord R, Holgate ST. Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin-sensitive asthma: its repeatability, absence of a late-phase reaction, and the role of histamine. J Allergy Clin Immunol 1989;84:232241.
  • 21
    Melillo G, Balzano G, Bianco S, et al. Oral and inhalation provocation tests for the diagnosis of aspirin-induced asthma. Report of the Interasthma Working Group on Standardization of Inhalation Provocation Tests in Aspirin-Induced Asthma. Allergy 2001;56:899911.
  • 22
    Pleskow WW, Stevenson DD, Mathison DA, Simon RA, Schatz M, Zeiger RS. Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin. J Allergy Clin Immunol 1983;71:574579.
  • 23
    Ortolani C, Mirone C, Fontana A, et al.. Study of mediators of anaphylaxis in nasal provocation in intolerant rhinitic patients. Ann Allergy1987;59:106112.
  • 24
    Patriarca G, Nucera E, Direnzo V, Schiaviano D, Pellegrino S, Fais G. Nasal provocation test with lysine acetylsalicylate in aspirin-sensitive patients. Ann Allergy 1991;67:6062.
  • 25
    Pawlowicz A, Williams R, Davies BH. Inhalation and nasal challenge in the diagnosis of aspirin-induced asthma. Allergy 1991;46:405409.
  • 26
    Schapowal A, Schmitz-Schumann M, Szczeklik A, Bruijnzel P, Hansel T, Virchovsen Chr. Lysine-aspirin nasal provocation and anterior rhinomanometry for the diagnosis of aspirin-sensitive asthma. Atemw-Lungenkrkh 1990;16:S1S5.
  • 27
    Milewski M, Mastalerz L, Niz ankowska E, Szczeklik A. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 1998;101:581586.
  • 28
    Alonso-Llamazares A. Nasal provocation tests. Allergy 2002;57:632635.
  • 29
    Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. BMJ 1975;1:6769.
  • 30
    Szczeklik ANizankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska M. Safety of specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2000;31:219225.
  • 31
    Stevenson DD, Simon RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001;108:4751.
  • 32
    Dahlén B, Szczeklik A, Murray JJ. Celecoxib in patients with asthma and aspirin-intolerance. N Engl J Med 2001;344:142.
  • 33
    Yoshida S, Ishizaki Y, Onuma K, Shoji T, Nagakawa H, Amayasu H. Selective cyclo-oxygenase 2 inhibitor in patients with aspirin-induced asthma. J Allergy Clin Immunol 2000;106:12011202.